Genomic and clinical characteristics of MET exon14 alterations in a large cohort of Chinese cancer patients revealed distinct features and a novel resistance mechanism for crizotinib
Keyword(s):
2020 ◽
Vol 19
(3)
◽
pp. e110-e116
◽
2005 ◽
Vol 22
(3)
◽
pp. 228-232
◽
2021 ◽
Vol 39
(15_suppl)
◽
pp. e14576-e14576
Keyword(s):